Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
GAB2 |
GRB2-associated binding protein 2, transcript variant 2 |
FXC00100
|
FHC00100
|
FNC00100N
|
FNC00100C
|
GPRIN1 |
G protein regulated inducer of neurite outgrowth 1 |
FXC00296
|
FHC00296
|
FNC00296N
|
FNC00296C
|
ARHGEF7 |
Rho guanine nucleotide exchange factor (GEF) 7, transcript variant 1 |
FXC00426
|
FHC00426
|
FNC00426N
|
FNC00426C
|
RAPGEF5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
FXC00490
|
FHC00490
|
FNC00490N
|
FNC00490C
|
RNMT |
RNA (guanine-7-) methyltransferase, transcript variant 2 |
FXC00528
|
FHC00528
|
FNC00528N
|
FNC00528C
|
RASGRP3 |
RAS guanyl releasing protein 3 (calcium and DAG-regulated), transcript variant 3 |
FXC00656
|
FHC00656
|
FNC00656N
|
FNC00656C
|
SHOC2 |
SHOC2 leucine-rich repeat scaffold protein, transcript variant 1 |
FXC00664
|
FHC00664
|
FNC00664N
|
FNC00664C
|
PAK4 |
p21 protein (Cdc42/Rac)-activated kinase 4, transcript variant 5 |
FXC00749
|
FHC00749
|
FNC00749N
|
FNC00749C
|
PAK5 |
p21 (RAC1) activated kinase 5 (PAK5), transcript variant 1 |
FXC00788
|
FHC00788
|
FNC00788N
|
FNC00788C
|
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6, transcript variant 1 |
FXC01015
|
FHC01015
|
FNC01015N
|
FNC01015C
|
PLCE1 |
phospholipase C, epsilon 1, transcript variant 1 |
FXC01171
|
FHC01171
|
FNC01171N
|
FNC01171C
|
SYNGAP1 |
synaptic Ras GTPase activating protein 1 |
FXC01186
|
FHC01186
|
FNC01186N
|
FNC01186C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
PTPN11 |
protein tyrosine phosphatase, non-receptor type 11, transcript variant 1 |
FXC01231
|
FHC01231
|
FNC01231N
|
FNC01231C
|
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor), transcript variant 5 |
FXC01260
|
FHC01260
|
FNC01260N
|
FNC01260C
|
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
FXC01262
|
FHC01262
|
FNC01262N
|
FNC01262C
|
RASAL1 |
RAS protein activator like 1 (GAP1 like), transcript variant 2 |
FXC01273
|
FHC01273
|
FNC01273N
|
FNC01273C
|
MAPK9 |
mitogen-activated protein kinase 9, transcript variant JNK2-b2 |
FXC01315
|
FHC01315
|
FNC01315N
|
FNC01315C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
IGF1 |
insulin-like growth factor 1 (somatomedin C), transcript variant 4 |
FXC01347
|
FHC01347
|
FNC01347N
|
FNC01347C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
CALM3 |
calmodulin 3 (phosphorylase kinase, delta) |
FXC01403
|
FHC01403
|
FNC01403N
|
FNC01403C
|
ABL1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase, transcript variant b |
FXC01406
|
FHC01406
|
FNC01406N
|
FNC01406C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
PLA2G6 |
phospholipase A2, group VI (cytosolic, calcium-independent), transcript variant 1 |
FXC01421
|
FHC01421
|
FNC01421N
|
FNC01421C
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A, transcript variant 2 |
FXC01444
|
FHC01444
|
FNC01444N
|
FNC01444C
|
GRB2 |
growth factor receptor-bound protein 2, transcript variant 1 |
FXC01485
|
FHC01485
|
FNC01485N
|
FNC01485C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
RHOA |
ras homolog family member A |
FXC01522
|
FHC01522
|
FNC01522N
|
FNC01522C
|
IKBKG |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma, transcript variant 3 |
FXC01524
|
FHC01524
|
FNC01524N
|
FNC01524C
|
NCOA3 |
nuclear receptor coactivator 3, transcript variant 3 |
FXC01529
|
FHC01529
|
FNC01529N
|
FNC01529C
|
PLD1 |
phospholipase D1, phosphatidylcholine-specific, transcript variant 2 |
FXC01544
|
FHC01544
|
FNC01544N
|
FNC01544C
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
FXC01574
|
FHC01574
|
FNC01574N
|
FNC01574C
|
IGF1R |
insulin-like growth factor 1 receptor, transcript variant 2 |
FXC01578
|
FHC01578
|
FNC01578N
|
FNC01578C
|
RGL1 |
ral guanine nucleotide dissociation stimulator-like 1, transcript variant 4 |
FXC01616
|
FHC01616
|
FNC01616N
|
FNC01616C
|
PLCG1 |
phospholipase C, gamma 1, transcript variant 1 |
FXC01646
|
FHC01646
|
FNC01646N
|
FNC01646C
|
TEK |
TEK tyrosine kinase, endothelial, transcript variant 1 |
FXC01718
|
FHC01718
|
FNC01718N
|
FNC01718C
|
RASA3 |
RAS p21 protein activator 3 |
FXC01834
|
FHC01834
|
FNC01834N
|
FNC01834C
|
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, transcript variant 2 |
FXC01839
|
FHC01839
|
FNC01839N
|
FNC01839C
|
FLT1 |
fms-related tyrosine kinase 1, transcript variant 1 |
FXC01847
|
FHC01847
|
FNC01847N
|
FNC01847C
|
RASGRF1 |
Ras protein-specific guanine nucleotide-releasing factor 1, transcript variant 3 |
FXC01848
|
FHC01848
|
FNC01848N
|
FNC01848C
|
PRKCSH |
protein kinase C substrate 80K-H, transcript variant 2 |
FXC01870
|
FHC01870
|
FNC01870N
|
FNC01870C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
ANGPT1 |
angiopoietin 1, transcript variant 1 |
FXC01948
|
FHC01948
|
FNC01948N
|
FNC01948C
|
GNB1 |
guanine nucleotide binding protein (G protein), beta polypeptide 1, transcript variant 1 |
FXC02090
|
FHC02090
|
FNC02090N
|
FNC02090C
|
GNG4 |
guanine nucleotide binding protein (G protein), gamma 4, transcript variant 2 |
FXC02107
|
FHC02107
|
FNC02107N
|
FNC02107C
|
ARF6 |
ADP-ribosylation factor 6 |
FXC02124
|
FHC02124
|
FNC02124N
|
FNC02124C
|
KITLG |
KIT ligand, transcript variant b |
FXC02130
|
FHC02130
|
FNC02130N
|
FNC02130C
|
GNG10 |
guanine nucleotide binding protein (G protein), gamma 10, transcript variant 1 |
FXC02147
|
FHC02147
|
FNC02147N
|
FNC02147C
|
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1, transcript variant 1 |
FXC02157
|
FHC02157
|
FNC02157N
|
FNC02157C
|
GNG12 |
guanine nucleotide binding protein (G protein), gamma 12 |
FXC02211
|
FHC02211
|
FNC02211N
|
FNC02211C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
PLA2G2E |
phospholipase A2, group IIE |
FXC02329
|
FHC02329
|
FNC02329N
|
FNC02329C
|
PDGFA |
platelet-derived growth factor alpha polypeptide, transcript variant 2 |
FXC02363
|
FHC02363
|
FNC02363N
|
FNC02363C
|
SOS2 |
son of sevenless homolog 2 (Drosophila) |
FXC02373
|
FHC02373
|
FNC02373N
|
FNC02373C
|
SOS1 |
son of sevenless homolog 1 (Drosophila) |
FXC02380
|
FHC02380
|
FNC02380N
|
FNC02380C
|
KCNH4 |
potassium channel, voltage gated eag related subfamily H, member 4 |
FXC02382
|
FHC02382
|
FNC02382N
|
FNC02382C
|
EFNA2 |
ephrin-A2 |
FXC02434
|
FHC02434
|
FNC02434N
|
FNC02434C
|
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
FXC02618
|
FHC02618
|
FNC02618N
|
FNC02618C
|
BAD |
BCL2-associated agonist of cell death, transcript variant 1 |
FXC02680
|
FHC02680
|
FNC02680N
|
FNC02680C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
RAB5B |
RAB5B, member RAS oncogene family, transcript variant 1 |
FXC02758
|
FHC02758
|
FNC02758N
|
FNC02758C
|
PLA2G2A |
phospholipase A2, group IIA (platelets, synovial fluid), transcript variant 1 |
FXC02783
|
FHC02783
|
FNC02783N
|
FNC02783C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta, transcript variant 3 |
FXC02835
|
FHC02835
|
FNC02835N
|
FNC02835C
|
PLD2 |
phospholipase D2, transcript variant 1 |
FXC02836
|
FHC02836
|
FNC02836N
|
FNC02836C
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
FXC02856
|
FHC02856
|
FNC02856N
|
FNC02856C
|
RAP1B |
RAP1B, member of RAS oncogene family, transcript variant 1 |
FXC02891
|
FHC02891
|
FNC02891N
|
FNC02891C
|
BCL2L1 |
BCL2-like 1, transcript variant 1 |
FXC03091
|
FHC03091
|
FNC03091N
|
FNC03091C
|
MAPK10 |
mitogen-activated protein kinase 10, transcript variant 3 |
FXC03139
|
FHC03139
|
FNC03139N
|
FNC03139C
|
GNG7 |
guanine nucleotide binding protein (G protein), gamma 7 |
FXC03295
|
FHC03295
|
FNC03295N
|
FNC03295C
|
PLA1A |
phospholipase A1 member A, transcript variant 1 |
FXC03520
|
FHC03520
|
FNC03520N
|
FNC03520C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
PRKCA |
protein kinase C, alpha |
FXC03611
|
FHC03611
|
FNC03611N
|
FNC03611C
|
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 1 |
FXC03635
|
FHC03635
|
FNC03635N
|
FNC03635C
|
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, transcript variant 1 |
FXC03657
|
FHC03657
|
FNC03657N
|
FNC03657C
|
PRKCG |
protein kinase C, gamma |
FXC03659
|
FHC03659
|
FNC03659N
|
FNC03659C
|
CSF1 |
colony stimulating factor 1 (macrophage), transcript variant 1 |
FXC03695
|
FHC03695
|
FNC03695N
|
FNC03695C
|
ORC3 |
origin recognition complex, subunit 3, transcript variant 1 |
FXC03740
|
FHC03740
|
FNC03740N
|
FNC03740C
|
SHC1 |
SHC (Src homology 2 domain containing) transforming protein 1, transcript variant 3 |
FXC03742
|
FHC03742
|
FNC03742N
|
FNC03742C
|
PKN1 |
protein kinase N1, transcript variant 1 |
FXC03745
|
FHC03745
|
FNC03745N
|
FNC03745C
|
GAB1 |
GRB2-associated binding protein 1, transcript variant 1 |
FXC03750
|
FHC03750
|
FNC03750N
|
FNC03750C
|
PKN2 |
protein kinase N2 |
FXC03784
|
FHC03784
|
FNC03784N
|
FNC03784C
|
ZAP70 |
zeta-chain (TCR) associated protein kinase 70kDa, transcript variant 1 |
FXC03901
|
FHC03901
|
FNC03901N
|
FNC03901C
|
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent), transcript variant 1 |
FXC03961
|
FHC03961
|
FNC03961N
|
FNC03961C
|
ANGPT4 |
angiopoietin 4 |
FXC04100
|
FHC04100
|
FNC04100N
|
FNC04100C
|
C6orf89 |
chromosome 6 open reading frame 89, transcript variant 2 |
FXC04403
|
FHC04403
|
FNC04403N
|
FNC04403C
|
FGF5 |
fibroblast growth factor 5, transcript variant 1 |
FXC05019
|
FHC05019
|
FNC05019N
|
FNC05019C
|
FOXO4 |
forkhead box O4, transcript variant 1 |
FXC05227
|
FHC05227
|
FNC05227N
|
FNC05227C
|
GNG13 |
guanine nucleotide binding protein (G protein), gamma 13 |
FXC05319
|
FHC05319
|
FNC05319N
|
FNC05319C
|
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
FXC05358
|
FHC05358
|
FNC05358N
|
FNC05358C
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
FXC05918
|
FHC05918
|
FNC05918N
|
FNC05918C
|
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2, transcript variant 2 |
FXC06059
|
FHC06059
|
FNC06059N
|
FNC06059C
|
PDGFB |
platelet-derived growth factor beta polypeptide, transcript variant 1 |
FXC06311
|
FHC06311
|
FNC06311N
|
FNC06311C
|
PLA2G1B |
phospholipase A2, group IB (pancreas) |
FXC06377
|
FHC06377
|
FNC06377N
|
FNC06377C
|
PLA2G2D |
phospholipase A2, group IID, transcript variant 1 |
FXC06378
|
FHC06378
|
FNC06378N
|
FNC06378C
|
PLA2G4D |
phospholipase A2, group IVD (cytosolic) |
FXC06382
|
FHC06382
|
FNC06382N
|
FNC06382C
|
PLA2G5 |
phospholipase A2, group V |
FXC06383
|
FHC06383
|
FNC06383N
|
FNC06383C
|
PRKACG |
protein kinase, cAMP-dependent, catalytic, gamma |
FXC06481
|
FHC06481
|
FNC06481N
|
FNC06481C
|
RAP1A |
RAP1A, member of RAS oncogene family, transcript variant 2 |
FXC06588
|
FHC06588
|
FNC06588N
|
FNC06588C
|
REL |
v-rel avian reticuloendotheliosis viral oncogene homolog, transcript variant 2 |
FXC06623
|
FHC06623
|
FNC06623N
|
FNC06623C
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A, transcript variant 1 |
FXC06624
|
FHC06624
|
FNC06624N
|
FNC06624C
|
GNB4 |
guanine nucleotide binding protein (G protein), beta polypeptide 4 |
FXC06872
|
FHC06872
|
FNC06872N
|
FNC06872C
|
NGF |
nerve growth factor (beta polypeptide) |
FXC07757
|
FHC07757
|
FNC07757N
|
FNC07757C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 2 |
FXC07774
|
FHC07774
|
FNC07774N
|
FNC07774C
|
PLA2G16 |
phospholipase A2, group XVI, transcript variant 1 |
FXC07990
|
FHC07990
|
FNC07990N
|
FNC07990C
|
PGF |
placental growth factor, transcript variant 1 |
FXC07993
|
FHC07993
|
FNC07993N
|
FNC07993C
|
GNB3 |
guanine nucleotide binding protein (G protein), beta polypeptide 3, transcript variant 1 |
FXC08063
|
FHC08063
|
FNC08063N
|
FNC08063C
|
INS |
insulin, transcript variant 1 |
FXC08231
|
FHC08231
|
FNC08231N
|
FNC08231C
|
ARHGAP9 |
Rho GTPase activating protein 9 |
FXC08262
|
FHC08262
|
FNC08262N
|
FNC08262C
|
FGF18 |
fibroblast growth factor 18 |
FXC08269
|
FHC08269
|
FNC08269N
|
FNC08269C
|
SPNS1 |
spinster homolog 1 (Drosophila), transcript variant 1 |
FXC08366
|
FHC08366
|
FNC08366N
|
FNC08366C
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
FXC08439
|
FHC08439
|
FNC08439N
|
FNC08439C
|
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
FXC08448
|
FHC08448
|
FNC08448N
|
FNC08448C
|
RALBP1 |
ralA binding protein 1 |
FXC08672
|
FHC08672
|
FNC08672N
|
FNC08672C
|
RIN1 |
Ras and Rab interactor 1 |
FXC08738
|
FHC08738
|
FNC08738N
|
FNC08738C
|
IL6 |
interleukin 6 |
FXC08788
|
FHC08788
|
FNC08788N
|
FNC08788C
|
FASLG |
Fas ligand (TNF superfamily, member 6), transcript variant 1 |
FXC08901
|
FHC08901
|
FNC08901N
|
FNC08901C
|
EFNA3 |
ephrin-A3 |
FXC08909
|
FHC08909
|
FNC08909N
|
FNC08909C
|
FGF12 |
fibroblast growth factor 12, transcript variant 2 |
FXC09106
|
FHC09106
|
FNC09106N
|
FNC09106C
|
GNGT1 |
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 |
FXC09285
|
FHC09285
|
FNC09285N
|
FNC09285C
|
CALML3 |
calmodulin-like 3 |
FXC09388
|
FHC09388
|
FNC09388N
|
FNC09388C
|
EFNA1 |
ephrin-A1, transcript variant 1 |
FXC09443
|
FHC09443
|
FNC09443N
|
FNC09443C
|
VEGFC |
vascular endothelial growth factor C |
FXC09559
|
FHC09559
|
FNC09559N
|
FNC09559C
|
EPHA2 |
EPH receptor A2 |
FXC09635
|
FHC09635
|
FNC09635N
|
FNC09635C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
VEGFB |
vascular endothelial growth factor B, transcript variant VEGFB-186 |
FXC09942
|
FHC09942
|
FNC09942N
|
FNC09942C
|
FGFR4 |
fibroblast growth factor receptor 4, transcript variant 1 |
FXC09979
|
FHC09979
|
FNC09979N
|
FNC09979C
|
FGF13 |
fibroblast growth factor 13, transcript variant 1 |
FXC09990
|
FHC09990
|
FNC09990N
|
FNC09990C
|
GNG3 |
guanine nucleotide binding protein (G protein), gamma 3 |
FXC10049
|
FHC10049
|
FNC10049N
|
FNC10049C
|
ETS2 |
v-ets avian erythroblastosis virus E26 oncogene homolog 2, transcript variant 1 |
FXC10074
|
FHC10074
|
FNC10074N
|
FNC10074C
|
FGF21 |
fibroblast growth factor 21 |
FXC10096
|
FHC10096
|
FNC10096N
|
FNC10096C
|
SHC3 |
SHC (Src homology 2 domain containing) transforming protein 3 |
FXC10206
|
FHC10206
|
FNC10206N
|
FNC10206C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
GNB2 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 |
FXC10441
|
FHC10441
|
FNC10441N
|
FNC10441C
|
FGFR3 |
fibroblast growth factor receptor 3
|
FXC10468
|
FHC10468
|
|
|
FGFR3 |
fibroblast growth factor receptor 3, transcript variant 1 |
FXC10478
|
FHC10478
|
FNC10478N
|
FNC10478C
|
CSF1R |
colony stimulating factor 1 receptor, transcript variant 1 |
FXC10479
|
FHC10479
|
FNC10479N
|
FNC10479C
|
RAB5A |
RAB5A, member RAS oncogene family, transcript variant 1 |
FXC10518
|
FHC10518
|
FNC10518N
|
FNC10518C
|
FGFR1 |
fibroblast growth factor receptor 1, transcript variant 3 |
FXC10532
|
FHC10532
|
FNC10532N
|
FNC10532C
|
PRKCB |
protein kinase C, beta, transcript variant 2 |
FXC10533
|
FHC10533
|
FNC10533N
|
FNC10533C
|
PRKACA |
protein kinase, cAMP-dependent, catalytic, alpha, transcript variant 1 |
FXC10564
|
FHC10564
|
FNC10564N
|
FNC10564C
|
RASSF1 |
Ras association (RalGDS/AF-6) domain family member 1, transcript variant A |
FXC10576
|
FHC10576
|
FNC10576N
|
FNC10576C
|
FGF1 |
fibroblast growth factor 1 (acidic), transcript variant 1 |
FXC10599
|
FHC10599
|
FNC10599N
|
FNC10599C
|
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2, transcript variant 1 |
FXC10622
|
FHC10622
|
FNC10622N
|
FNC10622C
|
RAB5C |
RAB5C, member RAS oncogene family, transcript variant 2 |
FXC10658
|
FHC10658
|
FNC10658N
|
FNC10658C
|
RRAS |
related RAS viral (r-ras) oncogene homolog |
FXC10666
|
FHC10666
|
FNC10666N
|
FNC10666C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
GNB5 |
guanine nucleotide binding protein (G protein), beta 5 |
FXC10771
|
FHC10771
|
FNC10771N
|
FNC10771C
|
PDGFB |
platelet-derived growth factor beta polypeptide |
FXC10772
|
FHC10772
|
FNC10772N
|
FNC10772C
|
FGF11 |
fibroblast growth factor 11, transcript variant 1 |
FXC10818
|
FHC10818
|
FNC10818N
|
FNC10818C
|
CHUK |
conserved helix-loop-helix ubiquitous kinase |
FXC10858
|
FHC10858
|
FNC10858N
|
FNC10858C
|
PLA2G2F |
phospholipase A2, group IIF |
FXC10921
|
FHC10921
|
FNC10921N
|
FNC10921C
|
MRAS |
muscle RAS oncogene homolog, transcript variant 1 |
FXC10922
|
FHC10922
|
FNC10922N
|
FNC10922C
|
STK4 |
serine/threonine kinase 4 |
FXC11122
|
FHC11122
|
FNC11122N
|
FNC11122C
|
INSR |
insulin receptor, transcript variant 2 |
FXC11132
|
FHC11132
|
FNC11132N
|
FNC11132C
|
RASAL2 |
RAS protein activator like 2, transcript variant 2 |
FXC11162
|
FHC11162
|
FNC11162N
|
FNC11162C
|
FGF16 |
fibroblast growth factor 16 |
FXC11178
|
FHC11178
|
FNC11178N
|
FNC11178C
|
ELK1 |
ELK1, member of ETS oncogene family, transcript variant 2 |
FXC11409
|
FHC11409
|
FNC11409N
|
FNC11409C
|
RASA2 |
RAS p21 protein activator 2, transcript variant 2 |
FXC11430
|
FHC11430
|
FNC11430N
|
FNC11430C
|
RASA4 |
RAS p21 protein activator 4, transcript variant 1 |
FXC11436
|
FHC11436
|
FNC11436N
|
FNC11436C
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
FXC11491
|
FHC11491
|
FNC11491N
|
FNC11491C
|
CDC42 |
cell division cycle 42, transcript variant 2 |
FXC11496
|
FHC11496
|
FNC11496N
|
FNC11496C
|
RASSF3 |
Ras association (RalGDS/AF-6) domain family member 3, transcript variant 1 |
FXC11728
|
FHC11728
|
FNC11728N
|
FNC11728C
|
FGF3 |
fibroblast growth factor 3 |
FXC11767
|
FHC11767
|
FNC11767N
|
FNC11767C
|
CALM2 |
calmodulin 2 (phosphorylase kinase, delta), transcript variant 2 |
FXC11793
|
FHC11793
|
FNC11793N
|
FNC11793C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 1 |
FXC11986
|
FHC11986
|
FNC11986N
|
FNC11986C
|
PAK3 |
p21 protein (Cdc42/Rac)-activated kinase 3, transcript variant 2 |
FXC12049
|
FHC12049
|
FNC12049N
|
FNC12049C
|
KSR2 |
kinase suppressor of ras 2 |
FXC12564
|
FHC12564
|
FNC12564N
|
FNC12564C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
MET |
MET proto-oncogene, receptor tyrosine kinase, transcript variant 2 |
FXC12649
|
FHC12649
|
FNC12649N
|
FNC12649C
|
RASA4 |
RAS p21 protein activator 4, transcript variant 1 |
FXC12747
|
FHC12747
|
FNC12747N
|
FNC12747C
|
VEGFA |
vascular endothelial growth factor A, transcript variant 6 |
FXC13139
|
FHC13139
|
FNC13139N
|
FNC13139C
|
RASA1 |
RAS p21 protein activator (GTPase activating protein) 1, transcript variant 1 |
FXC13661
|
FHC13661
|
FNC13661N
|
FNC13661C
|
PAK2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
FXC16509
|
FHC16509
|
FNC16509N
|
FNC16509C
|
RALGDS |
ral guanine nucleotide dissociation stimulator, transcript variant 1 |
FXC16602
|
FHC16602
|
|
|
GNG5 |
guanine nucleotide binding protein (G protein), gamma 5 |
FXC20387
|
FHC20387
|
FNC20387N
|
FNC20387C
|
EFNA4 |
ephrin-A4, transcript variant 1 |
FXC20599
|
FHC20599
|
FNC20599N
|
FNC20599C
|
RALB |
v-ral simian leukemia viral oncogene homolog B |
FXC21157
|
FHC21157
|
FNC21157N
|
FNC21157C
|
KCNH8 |
potassium channel, voltage gated eag related subfamily H, member 8 |
FXC21449
|
FHC21449
|
FNC21449N
|
FNC21449C
|
KDR |
kinase insert domain receptor (a type III receptor tyrosine kinase) |
FXC21921
|
FHC21921
|
FNC21921N
|
FNC21921C
|
PDGFC |
platelet derived growth factor C, transcript variant 1 |
FXC22085
|
FHC22085
|
FNC22085N
|
FNC22085C
|
FGF10 |
fibroblast growth factor 10 |
FXC22164
|
FHC22164
|
FNC22164N
|
FNC22164C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
RGL2 |
ral guanine nucleotide dissociation stimulator-like 2, transcript variant 1 |
FXC22583
|
FHC22583
|
FNC22583N
|
FNC22583C
|
VEGFA |
vascular endothelial growth factor A
|
FXC22633
|
FHC22633
|
|
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
ANGPT2 |
angiopoietin 2, transcript variant 1 |
FXC23170
|
FHC23170
|
FNC23170N
|
FNC23170C
|
FGF20 |
fibroblast growth factor 20 |
FXC23199
|
FHC23199
|
FNC23199N
|
FNC23199C
|
FGF17 |
fibroblast growth factor 17, transcript variant 1 |
FXC23209
|
FHC23209
|
FNC23209N
|
FNC23209C
|
CALML5 |
calmodulin-like 5 |
FXC23748
|
FHC23748
|
FNC23748N
|
FNC23748C
|
FGFR2 |
fibroblast growth factor receptor 2, transcript variant 1 |
FXC24041
|
FHC24041
|
FNC24041N
|
FNC24041C
|
FGFR2 |
fibroblast growth factor receptor 2, transcript variant 9 |
FXC24045
|
FHC24045
|
|
|
FGF19 |
fibroblast growth factor 19 |
FXC24356
|
FHC24356
|
FNC24356N
|
FNC24356C
|
FGF4 |
fibroblast growth factor 4 |
FXC24357
|
FHC24357
|
FNC24357N
|
FNC24357C
|
FGF23 |
fibroblast growth factor 23
|
FXC24560
|
FHC24560
|
|
|
BRAP |
BRCA1 associated protein |
FXC24886
|
FHC24886
|
FNC24886N
|
FNC24886C
|
FGF9 |
fibroblast growth factor 9 |
FXC24958
|
FHC24958
|
FNC24958N
|
FNC24958C
|
FGF14 |
fibroblast growth factor 14, transcript variant 2 |
FXC25055
|
FHC25055
|
FNC25055N
|
FNC25055C
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
SHC4 |
SHC (Src homology 2 domain containing) family, member 4 |
FXC25382
|
FHC25382
|
FNC25382N
|
FNC25382C
|
FGF7 |
fibroblast growth factor 7 |
FXC25383
|
FHC25383
|
FNC25383N
|
FNC25383C
|
GNGT2 |
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2, transcript variant 2 |
FXC26096
|
FHC26096
|
FNC26096N
|
FNC26096C
|
NGFR |
nerve growth factor receptor
|
FXC26099
|
FHC26099
|
|
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
GNG8 |
guanine nucleotide binding protein (G protein), gamma 8 |
FXC26701
|
FHC26701
|
FNC26701N
|
FNC26701C
|
TIAM1 |
T-cell lymphoma invasion and metastasis 1
|
FXC27150
|
FHC27150
|
|
|
FIGF |
c-fos induced growth factor (vascular endothelial growth factor D) |
FXC27307
|
FHC27307
|
FNC27307N
|
FNC27307C
|
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated), transcript variant 2 |
FXC28050
|
FHC28050
|
FNC28050N
|
FNC28050C
|
RASGRP4 |
RAS guanyl releasing protein 4, transcript variant a |
FXC30817
|
FHC30817
|
FNC30817N
|
FNC30817C
|
TBK1 |
TANK-binding kinase 1 |
FXC31490
|
FHC31490
|
FNC31490N
|
FNC31490C
|
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
FXC00116
|
FHC00116
|
FNC00116N
|
FNC00116C
|
TAOK1 |
TAO kinase 1, transcript variant 1 |
FXC00219
|
FHC00219
|
FNC00219N
|
FNC00219C
|
FASN |
fatty acid synthase |
FXC00314
|
FHC00314
|
FNC00314N
|
FNC00314C
|
RAPGEF2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
FXC00500
|
FHC00500
|
FNC00500N
|
FNC00500C
|
CACNA2D2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2, transcript variant 1 |
FXC00563
|
FHC00563
|
FNC00563N
|
FNC00563C
|
TAB2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2, transcript variant 1 |
FXC00616
|
FHC00616
|
FNC00616N
|
FNC00616C
|
RASGRP3 |
RAS guanyl releasing protein 3 (calcium and DAG-regulated), transcript variant 3 |
FXC00656
|
FHC00656
|
FNC00656N
|
FNC00656C
|
TAOK2 |
TAO kinase 2, transcript variant 2 |
FXC00670
|
FHC00670
|
FNC00670N
|
FNC00670C
|
MAPK8IP3 |
mitogen-activated protein kinase 8 interacting protein 3, transcript variant 1 |
FXC00728
|
FHC00728
|
FNC00728N
|
FNC00728C
|
TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
SYNGAP1 |
synaptic Ras GTPase activating protein 1 |
FXC01186
|
FHC01186
|
FNC01186N
|
FNC01186C
|
RPS6KA3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
FXC01272
|
FHC01272
|
FNC01272N
|
FNC01272C
|
NFKB2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100), transcript variant 2 |
FXC01287
|
FHC01287
|
FNC01287N
|
FNC01287C
|
ZAK |
sterile alpha motif and leucine zipper containing kinase AZK, transcript variant 1 |
FXC01289
|
FHC01289
|
FNC01289N
|
FNC01289C
|
TGFBR1 |
transforming growth factor, beta receptor 1, transcript variant 1 |
FXC01305
|
FHC01305
|
FNC01305N
|
FNC01305C
|
MAPK14 |
mitogen-activated protein kinase 14, transcript variant 1 |
FXC01309
|
FHC01309
|
FNC01309N
|
FNC01309C
|
NLK |
nemo-like kinase |
FXC01310
|
FHC01310
|
FNC01310N
|
FNC01310C
|
MAPK9 |
mitogen-activated protein kinase 9, transcript variant JNK2-b2 |
FXC01315
|
FHC01315
|
FNC01315N
|
FNC01315C
|
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
FXC01323
|
FHC01323
|
FNC01323N
|
FNC01323C
|
MAP4K3 |
mitogen-activated protein kinase kinase kinase kinase 3, transcript variant 1 |
FXC01352
|
FHC01352
|
FNC01352N
|
FNC01352C
|
MEF2C |
myocyte enhancer factor 2C, transcript variant 1 |
FXC01355
|
FHC01355
|
FNC01355N
|
FNC01355C
|
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
FXC01384
|
FHC01384
|
FNC01384N
|
FNC01384C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa), transcript variant 2 |
FXC01401
|
FHC01401
|
FNC01401N
|
FNC01401C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
PPP3CC |
protein phosphatase 3, catalytic subunit, gamma isozyme, transcript variant 2 |
FXC01443
|
FHC01443
|
FNC01443N
|
FNC01443C
|
MAP2K5 |
mitogen-activated protein kinase kinase 5, transcript variant 1 |
FXC01455
|
FHC01455
|
FNC01455N
|
FNC01455C
|
GRB2 |
growth factor receptor-bound protein 2, transcript variant 1 |
FXC01485
|
FHC01485
|
FNC01485N
|
FNC01485C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
IKBKG |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma, transcript variant 3 |
FXC01524
|
FHC01524
|
FNC01524N
|
FNC01524C
|
NCOA3 |
nuclear receptor coactivator 3, transcript variant 3 |
FXC01529
|
FHC01529
|
FNC01529N
|
FNC01529C
|
JUN |
jun proto-oncogene |
FXC01532
|
FHC01532
|
FNC01532N
|
FNC01532C
|
TRAF6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase, transcript variant 2 |
FXC01545
|
FHC01545
|
FNC01545N
|
FNC01545C
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
FXC01574
|
FHC01574
|
FNC01574N
|
FNC01574C
|
MAP3K2 |
mitogen-activated protein kinase kinase kinase 2 |
FXC01733
|
FHC01733
|
FNC01733N
|
FNC01733C
|
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
FXC01745
|
FHC01745
|
FNC01745N
|
FNC01745C
|
ATF2 |
activating transcription factor 2, transcript variant 1 |
FXC01751
|
FHC01751
|
FNC01751N
|
FNC01751C
|
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1, transcript variant 1 |
FXC01797
|
FHC01797
|
FNC01797N
|
FNC01797C
|
PPM1A |
protein phosphatase, Mg2+/Mn2+ dependent, 1A, transcript variant 1 |
FXC01828
|
FHC01828
|
FNC01828N
|
FNC01828C
|
RASGRF1 |
Ras protein-specific guanine nucleotide-releasing factor 1, transcript variant 3 |
FXC01848
|
FHC01848
|
FNC01848N
|
FNC01848C
|
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant 2 |
FXC01927
|
FHC01927
|
FNC01927N
|
FNC01927C
|
PTPN5 |
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant 1 |
FXC01928
|
FHC01928
|
FNC01928N
|
FNC01928C
|
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
FXC01934
|
FHC01934
|
FNC01934N
|
FNC01934C
|
DUSP16 |
dual specificity phosphatase 16 |
FXC02049
|
FHC02049
|
FNC02049N
|
FNC02049C
|
MAX |
MYC associated factor X, transcript variant 1 |
FXC02095
|
FHC02095
|
FNC02095N
|
FNC02095C
|
GNA12 |
guanine nucleotide binding protein (G protein) alpha 12, transcript variant 1 |
FXC02119
|
FHC02119
|
FNC02119N
|
FNC02119C
|
ARRB1 |
arrestin, beta 1, transcript variant 1 |
FXC02162
|
FHC02162
|
FNC02162N
|
FNC02162C
|
GNG12 |
guanine nucleotide binding protein (G protein), gamma 12 |
FXC02211
|
FHC02211
|
FNC02211N
|
FNC02211C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
PDGFA |
platelet-derived growth factor alpha polypeptide, transcript variant 2 |
FXC02363
|
FHC02363
|
FNC02363N
|
FNC02363C
|
SOS2 |
son of sevenless homolog 2 (Drosophila) |
FXC02373
|
FHC02373
|
FNC02373N
|
FNC02373C
|
SOS1 |
son of sevenless homolog 1 (Drosophila) |
FXC02380
|
FHC02380
|
FNC02380N
|
FNC02380C
|
KCNH4 |
potassium channel, voltage gated eag related subfamily H, member 4 |
FXC02382
|
FHC02382
|
FNC02382N
|
FNC02382C
|
TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
PPM1B |
protein phosphatase, Mg2+/Mn2+ dependent, 1B, transcript variant 1 |
FXC02617
|
FHC02617
|
FNC02617N
|
FNC02617C
|
STMN1 |
stathmin 1, transcript variant 3 |
FXC02683
|
FHC02683
|
FNC02683N
|
FNC02683C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
MAP3K3 |
mitogen-activated protein kinase kinase kinase 3, transcript variant 1 |
FXC02739
|
FHC02739
|
FNC02739N
|
FNC02739C
|
GADD45A |
growth arrest and DNA-damage-inducible, alpha, transcript variant 1 |
FXC02792
|
FHC02792
|
FNC02792N
|
FNC02792C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta, transcript variant 3 |
FXC02835
|
FHC02835
|
FNC02835N
|
FNC02835C
|
CRKL |
v-crk avian sarcoma virus CT10 oncogene homolog-like |
FXC02842
|
FHC02842
|
FNC02842N
|
FNC02842C
|
MAPK11 |
mitogen-activated protein kinase 11, transcript variant 1 |
FXC02847
|
FHC02847
|
FNC02847N
|
FNC02847C
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
FXC02856
|
FHC02856
|
FNC02856N
|
FNC02856C
|
RAP1B |
RAP1B, member of RAS oncogene family, transcript variant 1 |
FXC02891
|
FHC02891
|
FNC02891N
|
FNC02891C
|
GDNF |
glial cell derived neurotrophic factor, transcript variant 1 |
FXC03087
|
FHC03087
|
FNC03087N
|
FNC03087C
|
MAPK10 |
mitogen-activated protein kinase 10, transcript variant 3 |
FXC03139
|
FHC03139
|
FNC03139N
|
FNC03139C
|
NR4A1 |
nuclear receptor subfamily 4, group A, member 1 |
FXC03212
|
FHC03212
|
FNC03212N
|
FNC03212C
|
NTF4 |
neurotrophin 4 |
FXC03305
|
FHC03305
|
FNC03305N
|
FNC03305C
|
BDNF |
brain-derived neurotrophic factor, transcript variant 4 |
FXC03322
|
FHC03322
|
FNC03322N
|
FNC03322C
|
NTF3 |
neurotrophin 3, transcript variant 2 |
FXC03324
|
FHC03324
|
FNC03324N
|
FNC03324C
|
MOS |
v-mos Moloney murine sarcoma viral oncogene homolog |
FXC03345
|
FHC03345
|
FNC03345N
|
FNC03345C
|
FLNA |
filamin A, alpha, transcript variant 1 |
FXC03392
|
FHC03392
|
FNC03392N
|
FNC03392C
|
PPP5C |
protein phosphatase 5, catalytic subunit, transcript variant 1 |
FXC03434
|
FHC03434
|
FNC03434N
|
FNC03434C
|
ECSIT |
ECSIT signalling integrator, transcript variant 1 |
FXC03508
|
FHC03508
|
FNC03508N
|
FNC03508C
|
ARRB2 |
arrestin, beta 2, transcript variant 1 |
FXC03515
|
FHC03515
|
FNC03515N
|
FNC03515C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7, transcript variant 1 |
FXC03523
|
FHC03523
|
FNC03523N
|
FNC03523C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC03542
|
FHC03542
|
FNC03542N
|
FNC03542C
|
PRKCA |
protein kinase C, alpha |
FXC03611
|
FHC03611
|
FNC03611N
|
FNC03611C
|
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 1 |
FXC03635
|
FHC03635
|
FNC03635N
|
FNC03635C
|
DAXX |
death-domain associated protein, transcript variant 2 |
FXC03646
|
FHC03646
|
FNC03646N
|
FNC03646C
|
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, transcript variant 1 |
FXC03657
|
FHC03657
|
FNC03657N
|
FNC03657C
|
PRKCG |
protein kinase C, gamma |
FXC03659
|
FHC03659
|
FNC03659N
|
FNC03659C
|
PKN1 |
protein kinase N1, transcript variant 1 |
FXC03745
|
FHC03745
|
FNC03745N
|
FNC03745C
|
MAPK7 |
mitogen-activated protein kinase 7, transcript variant 3 |
FXC03754
|
FHC03754
|
FNC03754N
|
FNC03754C
|
PKN2 |
protein kinase N2 |
FXC03784
|
FHC03784
|
FNC03784N
|
FNC03784C
|
MKNK2 |
MAP kinase interacting serine/threonine kinase 2, transcript variant 2 |
FXC03791
|
FHC03791
|
FNC03791N
|
FNC03791C
|
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8, transcript variant 1 |
FXC03793
|
FHC03793
|
FNC03793N
|
FNC03793C
|
MECOM |
MDS1 and EVI1 complex locus |
FXC03843
|
FHC03843
|
FNC03843N
|
FNC03843C
|
PPP3R1 |
protein phosphatase 3, regulatory subunit B, alpha |
FXC03887
|
FHC03887
|
FNC03887N
|
FNC03887C
|
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent), transcript variant 1 |
FXC03961
|
FHC03961
|
FNC03961N
|
FNC03961C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC03984
|
FHC03984
|
FNC03984N
|
FNC03984C
|
ATF4 |
activating transcription factor 4, transcript variant 1 |
FXC04200
|
FHC04200
|
FNC04200N
|
FNC04200C
|
CACNG2 |
calcium channel, voltage-dependent, gamma subunit 2 |
FXC04418
|
FHC04418
|
FNC04418N
|
FNC04418C
|
CD14 |
CD14 molecule, transcript variant 1 |
FXC04493
|
FHC04493
|
FNC04493N
|
FNC04493C
|
DUSP1 |
dual specificity phosphatase 1 |
FXC04837
|
FHC04837
|
FNC04837N
|
FNC04837C
|
DUSP4 |
dual specificity phosphatase 4, transcript variant 1 |
FXC04844
|
FHC04844
|
FNC04844N
|
FNC04844C
|
DUSP6 |
dual specificity phosphatase 6, transcript variant 1 |
FXC04845
|
FHC04845
|
FNC04845N
|
FNC04845C
|
FAS |
Fas cell surface death receptor |
FXC04988
|
FHC04988
|
FNC04988N
|
FNC04988C
|
FGF5 |
fibroblast growth factor 5, transcript variant 1 |
FXC05019
|
FHC05019
|
FNC05019N
|
FNC05019C
|
GADD45G |
growth arrest and DNA-damage-inducible, gamma |
FXC05255
|
FHC05255
|
FNC05255N
|
FNC05255C
|
HSPA1L |
heat shock 70kDa protein 1-like |
FXC05465
|
FHC05465
|
FNC05465N
|
FNC05465C
|
IL1A |
interleukin 1, alpha |
FXC05509
|
FHC05509
|
FNC05509N
|
FNC05509C
|
IL1B |
interleukin 1, beta |
FXC05510
|
FHC05510
|
FNC05510N
|
FNC05510C
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
FXC05918
|
FHC05918
|
FNC05918N
|
FNC05918C
|
MAP3K4 |
mitogen-activated protein kinase kinase kinase 4, transcript variant 2 |
FXC05920
|
FHC05920
|
FNC05920N
|
FNC05920C
|
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1, transcript variant 2 |
FXC05924
|
FHC05924
|
FNC05924N
|
FNC05924C
|
MAPK12 |
mitogen-activated protein kinase 12, transcript variant 2 |
FXC05927
|
FHC05927
|
FNC05927N
|
FNC05927C
|
MAPK13 |
mitogen-activated protein kinase 13, transcript variant 1 |
FXC05928
|
FHC05928
|
FNC05928N
|
FNC05928C
|
DDIT3 |
DNA-damage-inducible transcript 3, transcript variant 5 |
FXC06075
|
FHC06075
|
FNC06075N
|
FNC06075C
|
PDGFB |
platelet-derived growth factor beta polypeptide, transcript variant 1 |
FXC06311
|
FHC06311
|
FNC06311N
|
FNC06311C
|
PLA2G4D |
phospholipase A2, group IVD (cytosolic) |
FXC06382
|
FHC06382
|
FNC06382N
|
FNC06382C
|
PRKACG |
protein kinase, cAMP-dependent, catalytic, gamma |
FXC06481
|
FHC06481
|
FNC06481N
|
FNC06481C
|
RAP1A |
RAP1A, member of RAS oncogene family, transcript variant 2 |
FXC06588
|
FHC06588
|
FNC06588N
|
FNC06588C
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A, transcript variant 1 |
FXC06624
|
FHC06624
|
FNC06624N
|
FNC06624C
|
RPS6KA6 |
ribosomal protein S6 kinase, 90kDa, polypeptide 6 |
FXC06696
|
FHC06696
|
FNC06696N
|
FNC06696C
|
SRF |
serum response factor (c-fos serum response element-binding transcription factor), transcript variant 1 |
FXC06986
|
FHC06986
|
FNC06986N
|
FNC06986C
|
TANK |
TRAF family member-associated NFKB activator, transcript variant 1 |
FXC07067
|
FHC07067
|
FNC07067N
|
FNC07067C
|
HSPA1A |
heat shock 70kDa protein 1A |
FXC07555
|
FHC07555
|
FNC07555N
|
FNC07555C
|
NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2, transcript variant e |
FXC07750
|
FHC07750
|
FNC07750N
|
FNC07750C
|
NGF |
nerve growth factor (beta polypeptide) |
FXC07757
|
FHC07757
|
FNC07757N
|
FNC07757C
|
DUSP5 |
dual specificity phosphatase 5 |
FXC07761
|
FHC07761
|
FNC07761N
|
FNC07761C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 2 |
FXC07774
|
FHC07774
|
FNC07774N
|
FNC07774C
|
PPP3CB |
protein phosphatase 3, catalytic subunit, beta isozyme, transcript variant 2 |
FXC07780
|
FHC07780
|
FNC07780N
|
FNC07780C
|
HSPA2 |
heat shock 70kDa protein 2 |
FXC08027
|
FHC08027
|
FNC08027N
|
FNC08027C
|
DUSP3 |
dual specificity phosphatase 3 |
FXC08096
|
FHC08096
|
FNC08096N
|
FNC08096C
|
GPI |
glucose-6-phosphate isomerase, transcript variant 2 |
FXC08209
|
FHC08209
|
FNC08209N
|
FNC08209C
|
FGF18 |
fibroblast growth factor 18 |
FXC08269
|
FHC08269
|
FNC08269N
|
FNC08269C
|
DUSP12 |
dual specificity phosphatase 12 |
FXC08271
|
FHC08271
|
FNC08271N
|
FNC08271C
|
CRK |
v-crk avian sarcoma virus CT10 oncogene homolog, transcript variant II |
FXC08374
|
FHC08374
|
FNC08374N
|
FNC08374C
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
FXC08439
|
FHC08439
|
FNC08439N
|
FNC08439C
|
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
FXC08484
|
FHC08484
|
FNC08484N
|
FNC08484C
|
NR4A1 |
nuclear receptor subfamily 4, group A, member 1, transcript variant 1 |
FXC08830
|
FHC08830
|
FNC08830N
|
FNC08830C
|
CASP3 |
caspase 3, apoptosis-related cysteine peptidase, transcript variant alpha |
FXC08865
|
FHC08865
|
FNC08865N
|
FNC08865C
|
FASLG |
Fas ligand (TNF superfamily, member 6), transcript variant 1 |
FXC08901
|
FHC08901
|
FNC08901N
|
FNC08901C
|
CACNG6 |
calcium channel, voltage-dependent, gamma subunit 6, transcript variant 1 |
FXC09061
|
FHC09061
|
FNC09061N
|
FNC09061C
|
FGF12 |
fibroblast growth factor 12, transcript variant 2 |
FXC09106
|
FHC09106
|
FNC09106N
|
FNC09106C
|
TRAF2 |
TNF receptor-associated factor 2 |
FXC09417
|
FHC09417
|
FNC09417N
|
FNC09417C
|
STK24 |
serine/threonine kinase 24, transcript variant 2 |
FXC09574
|
FHC09574
|
FNC09574N
|
FNC09574C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
HSPB1 |
heat shock 27kDa protein 1 |
FXC09723
|
FHC09723
|
FNC09723N
|
FNC09723C
|
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3, transcript variant 1 |
FXC09749
|
FHC09749
|
FNC09749N
|
FNC09749C
|
TAOK3 |
TAO kinase 3 |
FXC09805
|
FHC09805
|
FNC09805N
|
FNC09805C
|
FGFR4 |
fibroblast growth factor receptor 4, transcript variant 1 |
FXC09979
|
FHC09979
|
FNC09979N
|
FNC09979C
|
FGF13 |
fibroblast growth factor 13, transcript variant 1 |
FXC09990
|
FHC09990
|
FNC09990N
|
FNC09990C
|
FGF21 |
fibroblast growth factor 21 |
FXC10096
|
FHC10096
|
FNC10096N
|
FNC10096C
|
DUSP10 |
dual specificity phosphatase 10, transcript variant 1 |
FXC10264
|
FHC10264
|
FNC10264N
|
FNC10264C
|
MAP3K14 |
mitogen-activated protein kinase kinase kinase 14 |
FXC10327
|
FHC10327
|
FNC10327N
|
FNC10327C
|
HSPA6 |
heat shock 70kDa protein 6 (HSP70B') |
FXC10328
|
FHC10328
|
FNC10328N
|
FNC10328C
|
TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC10454
|
FHC10454
|
FNC10454N
|
FNC10454C
|
FGFR3 |
fibroblast growth factor receptor 3
|
FXC10468
|
FHC10468
|
|
|
FGFR3 |
fibroblast growth factor receptor 3, transcript variant 1 |
FXC10478
|
FHC10478
|
FNC10478N
|
FNC10478C
|
HSPA8 |
heat shock 70kDa protein 8, transcript variant 1 |
FXC10509
|
FHC10509
|
FNC10509N
|
FNC10509C
|
MAP2K3 |
mitogen-activated protein kinase kinase 3, transcript variant A |
FXC10525
|
FHC10525
|
FNC10525N
|
FNC10525C
|
FGFR1 |
fibroblast growth factor receptor 1, transcript variant 3 |
FXC10532
|
FHC10532
|
FNC10532N
|
FNC10532C
|
PRKCB |
protein kinase C, beta, transcript variant 2 |
FXC10533
|
FHC10533
|
FNC10533N
|
FNC10533C
|
PRKACA |
protein kinase, cAMP-dependent, catalytic, alpha, transcript variant 1 |
FXC10564
|
FHC10564
|
FNC10564N
|
FNC10564C
|
FGF1 |
fibroblast growth factor 1 (acidic), transcript variant 1 |
FXC10599
|
FHC10599
|
FNC10599N
|
FNC10599C
|
GADD45B |
growth arrest and DNA-damage-inducible, beta |
FXC10610
|
FHC10610
|
FNC10610N
|
FNC10610C
|
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2, transcript variant 1 |
FXC10622
|
FHC10622
|
FNC10622N
|
FNC10622C
|
RRAS |
related RAS viral (r-ras) oncogene homolog |
FXC10666
|
FHC10666
|
FNC10666N
|
FNC10666C
|
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7, transcript variant A |
FXC10678
|
FHC10678
|
FNC10678N
|
FNC10678C
|
MKNK1 |
MAP kinase interacting serine/threonine kinase 1, transcript variant 3 |
FXC10724
|
FHC10724
|
FNC10724N
|
FNC10724C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
PDGFB |
platelet-derived growth factor beta polypeptide |
FXC10772
|
FHC10772
|
FNC10772N
|
FNC10772C
|
FGF11 |
fibroblast growth factor 11, transcript variant 1 |
FXC10818
|
FHC10818
|
FNC10818N
|
FNC10818C
|
CHUK |
conserved helix-loop-helix ubiquitous kinase |
FXC10858
|
FHC10858
|
FNC10858N
|
FNC10858C
|
MRAS |
muscle RAS oncogene homolog, transcript variant 1 |
FXC10922
|
FHC10922
|
FNC10922N
|
FNC10922C
|
TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
MAP3K6 |
mitogen-activated protein kinase kinase kinase 6, transcript variant 1 |
FXC11020
|
FHC11020
|
FNC11020N
|
FNC11020C
|
STK4 |
serine/threonine kinase 4 |
FXC11122
|
FHC11122
|
FNC11122N
|
FNC11122C
|
FGF16 |
fibroblast growth factor 16 |
FXC11178
|
FHC11178
|
FNC11178N
|
FNC11178C
|
MAPKAPK3 |
mitogen-activated protein kinase-activated protein kinase 3, transcript variant 3 |
FXC11215
|
FHC11215
|
FNC11215N
|
FNC11215C
|
MAP2K7 |
mitogen-activated protein kinase kinase 7, transcript variant 3 |
FXC11270
|
FHC11270
|
FNC11270N
|
FNC11270C
|
STK3 |
serine/threonine kinase 3 |
FXC11390
|
FHC11390
|
FNC11390N
|
FNC11390C
|
ELK1 |
ELK1, member of ETS oncogene family, transcript variant 2 |
FXC11409
|
FHC11409
|
FNC11409N
|
FNC11409C
|
RASA2 |
RAS p21 protein activator 2, transcript variant 2 |
FXC11430
|
FHC11430
|
FNC11430N
|
FNC11430C
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
FXC11491
|
FHC11491
|
FNC11491N
|
FNC11491C
|
CDC42 |
cell division cycle 42, transcript variant 2 |
FXC11496
|
FHC11496
|
FNC11496N
|
FNC11496C
|
CACNG4 |
calcium channel, voltage-dependent, gamma subunit 4 |
FXC11543
|
FHC11543
|
FNC11543N
|
FNC11543C
|
RPS6KA4 |
ribosomal protein S6 kinase, 90kDa, polypeptide 4, transcript variant 3 |
FXC11752
|
FHC11752
|
FNC11752N
|
FNC11752C
|
MAPT |
microtubule-associated protein tau, transcript variant 4 |
FXC11766
|
FHC11766
|
FNC11766N
|
FNC11766C
|
FGF3 |
fibroblast growth factor 3 |
FXC11767
|
FHC11767
|
FNC11767N
|
FNC11767C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 1 |
FXC11986
|
FHC11986
|
FNC11986N
|
FNC11986C
|
NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2, transcript variant c |
FXC12007
|
FHC12007
|
FNC12007N
|
FNC12007C
|
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1, transcript variant 1 |
FXC12349
|
FHC12349
|
FNC12349N
|
FNC12349C
|
IL1R1 |
interleukin 1 receptor, type I, transcript variant 1 |
FXC12556
|
FHC12556
|
FNC12556N
|
FNC12556C
|
RPS6KA5 |
ribosomal protein S6 kinase, 90kDa, polypeptide 5, transcript variant 1 |
FXC12573
|
FHC12573
|
FNC12573N
|
FNC12573C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
MAP4K2 |
mitogen-activated protein kinase kinase kinase kinase 2 |
FXC12634
|
FHC12634
|
FNC12634N
|
FNC12634C
|
DUSP7 |
dual specificity phosphatase 7 |
FXC12730
|
FHC12730
|
FNC12730N
|
FNC12730C
|
RASA1 |
RAS p21 protein activator (GTPase activating protein) 1, transcript variant 1 |
FXC13661
|
FHC13661
|
FNC13661N
|
FNC13661C
|
CACNA1G |
calcium channel, voltage-dependent, T type, alpha 1G subunit, transcript variant 1 |
FXC15883
|
FHC15883
|
FNC15883N
|
FNC15883C
|
CACNA1I |
calcium channel, voltage-dependent, T type, alpha 1I subunit, transcript variant 1 |
FXC15884
|
FHC15884
|
FNC15884N
|
FNC15884C
|
CACNG7 |
calcium channel, voltage-dependent, gamma subunit 7 |
FXC15891
|
FHC15891
|
FNC15891N
|
FNC15891C
|
PAK2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
FXC16509
|
FHC16509
|
FNC16509N
|
FNC16509C
|
PTPRR |
protein tyrosine phosphatase, receptor type, R, transcript variant 2 |
FXC16533
|
FHC16533
|
FNC16533N
|
FNC16533C
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1, transcript variant 2 |
FXC20642
|
FHC20642
|
FNC20642N
|
FNC20642C
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1, transcript variant 2 |
FXC20644
|
FHC20644
|
|
|
ELK4 |
ELK4, ETS-domain protein (SRF accessory protein 1), transcript variant a |
FXC20788
|
FHC20788
|
FNC20788N
|
FNC20788C
|
MAPKAPK2 |
mitogen-activated protein kinase-activated protein kinase 2, transcript variant 2 |
FXC20795
|
FHC20795
|
FNC20795N
|
FNC20795C
|
IL1R2 |
interleukin 1 receptor, type II, transcript variant 1 |
FXC21118
|
FHC21118
|
FNC21118N
|
FNC21118C
|
ZAK |
sterile alpha motif and leucine zipper containing kinase AZK, transcript variant 2 |
FXC21226
|
FHC21226
|
FNC21226N
|
FNC21226C
|
KCNH8 |
potassium channel, voltage gated eag related subfamily H, member 8 |
FXC21449
|
FHC21449
|
FNC21449N
|
FNC21449C
|
MAP3K13 |
mitogen-activated protein kinase kinase kinase 13, transcript variant 1 |
FXC21785
|
FHC21785
|
FNC21785N
|
FNC21785C
|
FGF10 |
fibroblast growth factor 10 |
FXC22164
|
FHC22164
|
FNC22164N
|
FNC22164C
|
FGF20 |
fibroblast growth factor 20 |
FXC23199
|
FHC23199
|
FNC23199N
|
FNC23199C
|
FGF17 |
fibroblast growth factor 17, transcript variant 1 |
FXC23209
|
FHC23209
|
FNC23209N
|
FNC23209C
|
FGFR2 |
fibroblast growth factor receptor 2, transcript variant 1 |
FXC24041
|
FHC24041
|
FNC24041N
|
FNC24041C
|
FGFR2 |
fibroblast growth factor receptor 2, transcript variant 9 |
FXC24045
|
FHC24045
|
|
|
MAP3K11 |
mitogen-activated protein kinase kinase kinase 11 |
FXC24308
|
FHC24308
|
FNC24308N
|
FNC24308C
|
FGF19 |
fibroblast growth factor 19 |
FXC24356
|
FHC24356
|
FNC24356N
|
FNC24356C
|
FGF4 |
fibroblast growth factor 4 |
FXC24357
|
FHC24357
|
FNC24357N
|
FNC24357C
|
FGF23 |
fibroblast growth factor 23
|
FXC24560
|
FHC24560
|
|
|
MAP3K12 |
mitogen-activated protein kinase kinase kinase 12, transcript variant 2 |
FXC24753
|
FHC24753
|
FNC24753N
|
FNC24753C
|
FGF9 |
fibroblast growth factor 9 |
FXC24958
|
FHC24958
|
FNC24958N
|
FNC24958C
|
FGF14 |
fibroblast growth factor 14, transcript variant 2 |
FXC25055
|
FHC25055
|
FNC25055N
|
FNC25055C
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
FGF7 |
fibroblast growth factor 7 |
FXC25383
|
FHC25383
|
FNC25383N
|
FNC25383C
|
CACNG3 |
calcium channel, voltage-dependent, gamma subunit 3 |
FXC25636
|
FHC25636
|
FNC25636N
|
FNC25636C
|
MAP2K4 |
mitogen-activated protein kinase kinase 4, transcript variant 1 |
FXC25904
|
FHC25904
|
FNC25904N
|
FNC25904C
|
CACNG1 |
calcium channel, voltage-dependent, gamma subunit 1 |
FXC26161
|
FHC26161
|
FNC26161N
|
FNC26161C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated), transcript variant 2 |
FXC28050
|
FHC28050
|
FNC28050N
|
FNC28050C
|
JUND |
jun D proto-oncogene, transcript variant 1 |
FXC28593
|
FHC28593
|
FNC28593N
|
FNC28593C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
CACNA1F |
calcium channel, voltage-dependent, L type, alpha 1F subunit, transcript variant 1 |
FXC29434
|
FHC29434
|
FNC29434N
|
FNC29434C
|
FLNC |
filamin C, gamma, transcript variant 1 |
FXC30232
|
FHC30232
|
FNC30232N
|
FNC30232C
|
CACNA2D4 |
calcium channel, voltage-dependent, alpha 2/delta subunit 4 |
FXC30516
|
FHC30516
|
FNC30516N
|
FNC30516C
|
MAPKAPK5 |
mitogen-activated protein kinase-activated protein kinase 5, transcript variant 1 |
FXC30551
|
FHC30551
|
FNC30551N
|
FNC30551C
|
CACNA1H |
calcium channel, voltage-dependent, T type, alpha 1H subunit, transcript variant 1 |
FXC30646
|
FHC30646
|
FNC30646N
|
FNC30646C
|
RASGRP4 |
RAS guanyl releasing protein 4, transcript variant a |
FXC30817
|
FHC30817
|
FNC30817N
|
FNC30817C
|
RELB |
v-rel avian reticuloendotheliosis viral oncogene homolog B |
FXC30830
|
FHC30830
|
FNC30830N
|
FNC30830C
|
TAB1 |
TGF-beta activated kinase 1/MAP3K7 binding protein 1, transcript variant alpha |
FXC31603
|
FHC31603
|
FNC31603N
|
FNC31603C
|
DTX4 |
deltex 4, E3 ubiquitin ligase, transcript variant 1 |
FXC00152
|
FHC00152
|
FNC00152N
|
FNC00152C
|
DVL1 |
dishevelled segment polarity protein 1 |
FXC00360
|
FHC00360
|
FNC00360N
|
FNC00360C
|
MAML1 |
mastermind-like transcriptional coactivator 1 |
FXC00454
|
FHC00454
|
FNC00454N
|
FNC00454C
|
NCSTN |
nicastrin, transcript variant 1 |
FXC00480
|
FHC00480
|
FNC00480N
|
FNC00480C
|
DTX1 |
deltex 1, E3 ubiquitin ligase |
FXC01256
|
FHC01256
|
FNC01256N
|
FNC01256C
|
PSEN1 |
presenilin 1, transcript variant 1 |
FXC01329
|
FHC01329
|
FNC01329N
|
FNC01329C
|
MAML2 |
mastermind-like transcriptional coactivator 2 |
FXC01637
|
FHC01637
|
FNC01637N
|
FNC01637C
|
EP300 |
E1A binding protein p300 |
FXC01787
|
FHC01787
|
FNC01787N
|
FNC01787C
|
MAML3 |
mastermind-like transcriptional coactivator 3 |
FXC02055
|
FHC02055
|
FNC02055N
|
FNC02055C
|
CTBP2 |
C-terminal binding protein 2, transcript variant 1 |
FXC02077
|
FHC02077
|
FNC02077N
|
FNC02077C
|
HDAC1 |
histone deacetylase 1 |
FXC02563
|
FHC02563
|
FNC02563N
|
FNC02563C
|
MFNG |
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase, transcript variant 1 |
FXC02848
|
FHC02848
|
FNC02848N
|
FNC02848C
|
DVL3 |
dishevelled segment polarity protein 3 |
FXC03291
|
FHC03291
|
FNC03291N
|
FNC03291C
|
HES1 |
hes family bHLH transcription factor 1 |
FXC03412
|
FHC03412
|
FNC03412N
|
FNC03412C
|
CTBP1 |
C-terminal binding protein 1, transcript variant 1 |
FXC03687
|
FHC03687
|
FNC03687N
|
FNC03687C
|
DVL2 |
dishevelled segment polarity protein 2 |
FXC03710
|
FHC03710
|
FNC03710N
|
FNC03710C
|
RBPJ |
recombination signal binding protein for immunoglobulin kappa J region, transcript variant 1 |
FXC03722
|
FHC03722
|
FNC03722N
|
FNC03722C
|
KAT2A |
K(lysine) acetyltransferase 2A |
FXC03762
|
FHC03762
|
FNC03762N
|
FNC03762C
|
CIR1 |
corepressor interacting with RBPJ, 1 |
FXC03939
|
FHC03939
|
FNC03939N
|
FNC03939C
|
APH1B |
APH1B gamma secretase subunit, transcript variant 1 |
FXC04124
|
FHC04124
|
FNC04124N
|
FNC04124C
|
DTX3 |
deltex 3, E3 ubiquitin ligase, transcript variant 1 |
FXC04835
|
FHC04835
|
FNC04835N
|
FNC04835C
|
HDAC2 |
histone deacetylase 2 |
FXC05328
|
FHC05328
|
FNC05328N
|
FNC05328C
|
NOTCH3 |
notch 3
|
FXC06174
|
FHC06174
|
|
|
SNW1 |
SNW domain containing 1 |
FXC06926
|
FHC06926
|
FNC06926N
|
FNC06926C
|
NCOR2 |
nuclear receptor corepressor 2 |
FXC07721
|
FHC07721
|
FNC07721N
|
FNC07721C
|
PSENEN |
presenilin enhancer gamma secretase subunit, transcript variant 1 |
FXC08437
|
FHC08437
|
FNC08437N
|
FNC08437C
|
CTBP1 |
C-terminal binding protein 1, transcript variant 1 |
FXC08566
|
FHC08566
|
FNC08566N
|
FNC08566C
|
PSEN2 |
presenilin 2, transcript variant 1 |
FXC09882
|
FHC09882
|
FNC09882N
|
FNC09882C
|
DLL1 |
delta-like 1 (Drosophila) |
FXC10744
|
FHC10744
|
FNC10744N
|
FNC10744C
|
UBE2V1 |
ubiquitin-conjugating enzyme E2 variant 1, transcript variant 1 |
FXC11127
|
FHC11127
|
FNC11127N
|
FNC11127C
|
NUMBL |
numb homolog (Drosophila)-like, transcript variant 1 |
FXC11134
|
FHC11134
|
FNC11134N
|
FNC11134C
|
KAT2B |
K(lysine) acetyltransferase 2B |
FXC11610
|
FHC11610
|
FNC11610N
|
FNC11610C
|
CREBBP |
CREB binding protein, transcript variant 1 |
FXC11778
|
FHC11778
|
FNC11778N
|
FNC11778C
|
ADAM17 |
ADAM metallopeptidase domain 17 |
FXC14599
|
FHC14599
|
|
|
NOTCH2 |
notch 2, transcript variant 1 |
FXC20506
|
FHC20506
|
FNC20506N
|
FNC20506C
|
DTX3L |
deltex 3 like, E3 ubiquitin ligase |
FXC21667
|
FHC21667
|
FNC21667N
|
FNC21667C
|
JAG1 |
jagged 1 |
FXC26911
|
FHC26911
|
FNC26911N
|
FNC26911C
|
RBPJL |
recombination signal binding protein for immunoglobulin kappa J region-like, transcript variant 1 |
FXC27032
|
FHC27032
|
FNC27032N
|
FNC27032C
|
NOTCH4 |
notch 4 |
FXC29150
|
FHC29150
|
FNC29150N
|
FNC29150C
|
APH1A |
APH1A gamma secretase subunit, transcript variant 2 |
FXC29569
|
FHC29569
|
FNC29569N
|
FNC29569C
|
NOTCH1 |
notch 1 |
FXC30334
|
FHC30334
|
FNC30334N
|
FNC30334C
|
HDAC2 |
histone deacetylase 2, transcript variant 1 |
|
FHC31712
|
FNC31712N
|
FNC31712C
|
ZFYVE16 |
zinc finger, FYVE domain containing 16, transcript variant 1 |
FXC00047
|
FHC00047
|
FNC00047N
|
FNC00047C
|
SMURF1 |
SMAD specific E3 ubiquitin protein ligase 1, transcript variant 1 |
FXC00259
|
FHC00259
|
FNC00259N
|
FNC00259C
|
SMURF2 |
SMAD specific E3 ubiquitin protein ligase 2 |
FXC00356
|
FHC00356
|
FNC00356N
|
FNC00356C
|
ZFYVE9 |
zinc finger, FYVE domain containing 9 |
FXC01024
|
FHC01024
|
FNC01024N
|
FNC01024C
|
LTBP1 |
latent transforming growth factor beta binding protein 1, transcript variant 3 |
FXC01235
|
FHC01235
|
FNC01235N
|
FNC01235C
|
PPP2R1A |
protein phosphatase 2, regulatory subunit A, alpha, transcript variant 1 |
FXC01251
|
FHC01251
|
FNC01251N
|
FNC01251C
|
TGFBR1 |
transforming growth factor, beta receptor 1, transcript variant 1 |
FXC01305
|
FHC01305
|
FNC01305N
|
FNC01305C
|
BMPR2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
FXC01318
|
FHC01318
|
FNC01318N
|
FNC01318C
|
RBL1 |
retinoblastoma-like 1, transcript variant 1 |
FXC01328
|
FHC01328
|
FNC01328N
|
FNC01328C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
RPS6KB1 |
ribosomal protein S6 kinase, 70kDa, polypeptide 1, transcript variant 1 |
FXC01400
|
FHC01400
|
FNC01400N
|
FNC01400C
|
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa), transcript variant 2 |
FXC01401
|
FHC01401
|
FNC01401N
|
FNC01401C
|
ACVR1B |
activin A receptor, type IB, transcript variant 1 |
FXC01408
|
FHC01408
|
FNC01408N
|
FNC01408C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
PPP2CA |
protein phosphatase 2, catalytic subunit, alpha isozyme |
FXC01506
|
FHC01506
|
FNC01506N
|
FNC01506C
|
RHOA |
ras homolog family member A |
FXC01522
|
FHC01522
|
FNC01522N
|
FNC01522C
|
SMAD4 |
SMAD family member 4 |
FXC01560
|
FHC01560
|
FNC01560N
|
FNC01560C
|
SMAD7 |
SMAD family member 7, transcript variant 1 |
FXC01575
|
FHC01575
|
FNC01575N
|
FNC01575C
|
PPP2R1B |
protein phosphatase 2, regulatory subunit A, beta, transcript variant 1 |
FXC01775
|
FHC01775
|
FNC01775N
|
FNC01775C
|
EP300 |
E1A binding protein p300 |
FXC01787
|
FHC01787
|
FNC01787N
|
FNC01787C
|
SKP1 |
S-phase kinase-associated protein 1, transcript variant 2 |
FXC01803
|
FHC01803
|
FNC01803N
|
FNC01803C
|
THBS1 |
thrombospondin 1 |
FXC01829
|
FHC01829
|
FNC01829N
|
FNC01829C
|
SMAD9 |
SMAD family member 9, transcript variant a |
FXC02137
|
FHC02137
|
FNC02137N
|
FNC02137C
|
SMAD1 |
SMAD family member 1 |
FXC02183
|
FHC02183
|
FNC02183N
|
FNC02183C
|
INHBA |
inhibin, beta A |
FXC02222
|
FHC02222
|
FNC02222N
|
FNC02222C
|
BMP2 |
bone morphogenetic protein 2 |
FXC02340
|
FHC02340
|
FNC02340N
|
FNC02340C
|
TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
NBL1 |
neuroblastoma 1, DAN family BMP antagonist |
FXC02584
|
FHC02584
|
FNC02584N
|
FNC02584C
|
BAMBI |
BMP and activin membrane-bound inhibitor |
FXC02626
|
FHC02626
|
FNC02626N
|
FNC02626C
|
SMAD3 |
SMAD family member 3, transcript variant 1 |
FXC02648
|
FHC02648
|
FNC02648N
|
FNC02648C
|
TGIF2 |
TGFB-induced factor homeobox 2, transcript variant 2 |
FXC03092
|
FHC03092
|
FNC03092N
|
FNC03092C
|
BMP4 |
bone morphogenetic protein 4, transcript variant 1 |
FXC03136
|
FHC03136
|
FNC03136N
|
FNC03136C
|
ID1 |
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein, transcript variant 2 |
FXC03244
|
FHC03244
|
FNC03244N
|
FNC03244C
|
SMAD2 |
SMAD family member 2, transcript variant 1 |
FXC03382
|
FHC03382
|
FNC03382N
|
FNC03382C
|
TGIF1 |
TGFB-induced factor homeobox 1, transcript variant 1 |
FXC03413
|
FHC03413
|
FNC03413N
|
FNC03413C
|
BMPR1B |
bone morphogenetic protein receptor, type IB, transcript variant 2 |
FXC03435
|
FHC03435
|
FNC03435N
|
FNC03435C
|
BMP5 |
bone morphogenetic protein 5 |
FXC03493
|
FHC03493
|
FNC03493N
|
FNC03493C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC03542
|
FHC03542
|
FNC03542N
|
FNC03542C
|
ACVR1 |
activin A receptor, type I, transcript variant 1 |
FXC03971
|
FHC03971
|
FNC03971N
|
FNC03971C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC03984
|
FHC03984
|
FNC03984N
|
FNC03984C
|
CUL1 |
cullin 1 |
FXC04681
|
FHC04681
|
FNC04681N
|
FNC04681C
|
DCN |
decorin, transcript variant A1 |
FXC04713
|
FHC04713
|
FNC04713N
|
FNC04713C
|
ID2 |
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
FXC05482
|
FHC05482
|
FNC05482N
|
FNC05482C
|
INHBB |
inhibin, beta B |
FXC05519
|
FHC05519
|
FNC05519N
|
FNC05519C
|
PSG1 |
pregnancy specific beta-1-glycoprotein 1, transcript variant 2 |
FXC06508
|
FHC06508
|
FNC06508N
|
FNC06508C
|
RBX1 |
ring-box 1, E3 ubiquitin protein ligase |
FXC06613
|
FHC06613
|
FNC06613N
|
FNC06613C
|
SMAD5 |
SMAD family member 5, transcript variant 1 |
FXC06899
|
FHC06899
|
FNC06899N
|
FNC06899C
|
CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), transcript variant 1 |
FXC07728
|
FHC07728
|
FNC07728N
|
FNC07728C
|
SP1 |
Sp1 transcription factor, transcript variant 1 |
FXC07743
|
FHC07743
|
FNC07743N
|
FNC07743C
|
FST |
follistatin, transcript variant FST344 |
FXC08163
|
FHC08163
|
FNC08163N
|
FNC08163C
|
GARS |
glycyl-tRNA synthetase |
FXC08346
|
FHC08346
|
FNC08346N
|
FNC08346C
|
BMP7 |
bone morphogenetic protein 7 |
FXC08377
|
FHC08377
|
FNC08377N
|
FNC08377C
|
TFDP1 |
transcription factor Dp-1, transcript variant 1 |
FXC08570
|
FHC08570
|
FNC08570N
|
FNC08570C
|
PITX2 |
paired-like homeodomain 2, transcript variant 3 |
FXC08718
|
FHC08718
|
FNC08718N
|
FNC08718C
|
ACVR1C |
activin A receptor, type IC, transcript variant 1 |
FXC09109
|
FHC09109
|
FNC09109N
|
FNC09109C
|
BMPR1A |
bone morphogenetic protein receptor, type IA |
FXC09257
|
FHC09257
|
FNC09257N
|
FNC09257C
|
E2F4 |
E2F transcription factor 4, p107/p130-binding |
FXC09474
|
FHC09474
|
FNC09474N
|
FNC09474C
|
ID3 |
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
FXC09826
|
FHC09826
|
FNC09826N
|
FNC09826C
|
LEFTY1 |
left-right determination factor 1 |
FXC10214
|
FHC10214
|
FNC10214N
|
FNC10214C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC10454
|
FHC10454
|
FNC10454N
|
FNC10454C
|
TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
E2F5 |
E2F transcription factor 5, p130-binding, transcript variant 1 |
FXC10985
|
FHC10985
|
FNC10985N
|
FNC10985C
|
RPS6KB2 |
ribosomal protein S6 kinase, 70kDa, polypeptide 2 |
FXC11419
|
FHC11419
|
FNC11419N
|
FNC11419C
|
ACVR2A |
activin A receptor, type IIA, transcript variant 2 |
FXC11423
|
FHC11423
|
FNC11423N
|
FNC11423C
|
ACVR2B |
activin A receptor, type IIB |
FXC11748
|
FHC11748
|
FNC11748N
|
FNC11748C
|
CREBBP |
CREB binding protein, transcript variant 1 |
FXC11778
|
FHC11778
|
FNC11778N
|
FNC11778C
|
NODAL |
nodal growth differentiation factor |
FXC12598
|
FHC12598
|
FNC12598N
|
FNC12598C
|
SMAD6 |
SMAD family member 6, transcript variant 1 |
FXC12705
|
FHC12705
|
FNC12705N
|
FNC12705C
|
LEFTY2 |
left-right determination factor 2, transcript variant 1 |
FXC20839
|
FHC20839
|
FNC20839N
|
FNC20839C
|
BMP6 |
bone morphogenetic protein 6 |
FXC22433
|
FHC22433
|
FNC22433N
|
FNC22433C
|
PPP2CB |
protein phosphatase 2, catalytic subunit, beta isozyme |
FXC23231
|
FHC23231
|
FNC23231N
|
FNC23231C
|
AMHR2 |
anti-Mullerian hormone receptor, type II, transcript variant 1 |
FXC24752
|
FHC24752
|
FNC24752N
|
FNC24752C
|
INHBC |
inhibin, beta C |
FXC24781
|
FHC24781
|
FNC24781N
|
FNC24781C
|
INHBE |
inhibin, beta E |
FXC24782
|
FHC24782
|
FNC24782N
|
FNC24782C
|
IFNG |
interferon, gamma |
FXC24802
|
FHC24802
|
FNC24802N
|
FNC24802C
|
TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
NOG |
noggin |
FXC26122
|
FHC26122
|
|
|
ROCK1 |
Rho-associated, coiled-coil containing protein kinase 1 |
FXC26266
|
FHC26266
|
FNC26266N
|
FNC26266C
|
AMH |
anti-Mullerian hormone |
FXC26382
|
FHC26382
|
FNC26382N
|
FNC26382C
|
GDF5 |
growth differentiation factor 5 |
FXC26979
|
FHC26979
|
FNC26979N
|
FNC26979C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|